PRESS RELEASE published on 08/10/2023 at 14:30, 2 years 5 months ago Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates
PRESS RELEASE published on 08/09/2023 at 14:30, 2 years 5 months ago Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
PRESS RELEASE published on 08/08/2023 at 14:30, 2 years 5 months ago Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease
PRESS RELEASE published on 08/07/2023 at 14:30, 2 years 5 months ago Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea
PRESS RELEASE published on 08/03/2023 at 14:30, 2 years 5 months ago Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC
PRESS RELEASE published on 08/02/2023 at 14:30, 2 years 5 months ago REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th
PRESS RELEASE published on 08/01/2023 at 14:40, 2 years 5 months ago Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)
PRESS RELEASE published on 07/27/2023 at 14:30, 2 years 6 months ago In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon
PRESS RELEASE published on 07/26/2023 at 14:30, 2 years 6 months ago Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 07/25/2023 at 14:30, 2 years 6 months ago Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton"
Published on 01/30/2026 at 14:00, 1 hour 45 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 10 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 7 hours 45 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 13 hours 30 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 15 hours 45 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 15:33, 12 minutes ago Original-Research: Aroundtown SA (von First Berlin Equity Research GmbH): Kaufen
Published on 01/30/2026 at 15:29, 16 minutes ago Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch Ratings
Published on 01/30/2026 at 14:52, 53 minutes ago Edison issues report on Henderson Far East Income (HFEL)
Published on 01/30/2026 at 14:11, 1 hour 34 minutes ago SBF AG expects stable to positive business development in a challenging environment for 2026
Published on 01/30/2026 at 13:30, 2 hours 15 minutes ago North Peak Expands Wabash Gold Mineralization at Prospect Mountain, Nevada
Published on 01/29/2026 at 18:00, 21 hours 45 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
